Bioactivity-Guided Isolation of Antistroke Compounds from <i>Gymnadenia conopsea</i> (L.) R. Br.

A bioactivity-guided separation strategy was used to identify novel antistroke compounds from <i>Gymnadenia conopsea</i> (L.) R. Br., a medicinal plant. As a result, 4 undescribed compounds (<b>1–2</b>, <b>13</b>, and <b>17</b>) and 13 known compounds,...

Full description

Saved in:
Bibliographic Details
Main Authors: Juan Qin, Shiyi Xue, Chao Xu, Jian Jin, Jianbin Wang, Hailian Yuan, Liang Liu
Format: Article
Language:English
Published: MDPI AG 2024-09-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/29/18/4389
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850260143003926528
author Juan Qin
Shiyi Xue
Chao Xu
Jian Jin
Jianbin Wang
Hailian Yuan
Liang Liu
author_facet Juan Qin
Shiyi Xue
Chao Xu
Jian Jin
Jianbin Wang
Hailian Yuan
Liang Liu
author_sort Juan Qin
collection DOAJ
description A bioactivity-guided separation strategy was used to identify novel antistroke compounds from <i>Gymnadenia conopsea</i> (L.) R. Br., a medicinal plant. As a result, 4 undescribed compounds (<b>1–2</b>, <b>13</b>, and <b>17</b>) and 13 known compounds, including 1 new natural product (<b>3</b>), were isolated from <i>G. conopsea.</i> The structures of these compounds were elucidated through comprehensive spectroscopic techniques, such as 1D/2D nuclear magnetic resonance (NMR) spectroscopy, high-resolution electrospray ionization mass spectrometry (HRESIMS), and quantum chemical calculations. An oxygen–glucose deprivation/reoxygenation (OGD/R)-injured rat pheochromocytoma (PC12) cell model was used to evaluate the antistroke effects of the isolates. Compounds <b>1–2</b>, <b>10–11</b>, <b>13–15</b>, and <b>17</b> provided varying degrees of protection against OGD/R injury in the PC12 cells at concentrations of 12.5, 25, and 50 µM. Among the tested compounds, compound <b>17</b> demonstrated the most potent neuroprotective effect, which was equivalent to that of the positive control drug (edaravone). Then, transcriptomic and bioinformatics analyses were conducted to reveal the regulatory effect of compound <b>17</b> on gene expression. In addition, quantitative real-time PCR (qPCR) was performed to verify the results of the transcriptomic and bioinformatics analyses. These results suggest that the in vitro antistroke effect of compound <b>17</b> may be associated with the regulation of the <i>Col27a1</i> gene. Thus, compound <b>17</b> is a promising candidate for the development of novel antistroke drugs derived from natural products, and this topic should be further studied.
format Article
id doaj-art-d4ea3f800f464d078cb132d10a62ba6b
institution OA Journals
issn 1420-3049
language English
publishDate 2024-09-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj-art-d4ea3f800f464d078cb132d10a62ba6b2025-08-20T01:55:42ZengMDPI AGMolecules1420-30492024-09-012918438910.3390/molecules29184389Bioactivity-Guided Isolation of Antistroke Compounds from <i>Gymnadenia conopsea</i> (L.) R. Br.Juan Qin0Shiyi Xue1Chao Xu2Jian Jin3Jianbin Wang4Hailian Yuan5Liang Liu6Institute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, ChinaInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, ChinaCollege of Animal Science and Technology, Yangzhou University, Yangzhou 225009, ChinaCollege of Animal Science and Technology, Yangzhou University, Yangzhou 225009, ChinaInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, ChinaInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, ChinaInstitute of Translational Medicine, Medical College, Yangzhou University, Yangzhou 225009, ChinaA bioactivity-guided separation strategy was used to identify novel antistroke compounds from <i>Gymnadenia conopsea</i> (L.) R. Br., a medicinal plant. As a result, 4 undescribed compounds (<b>1–2</b>, <b>13</b>, and <b>17</b>) and 13 known compounds, including 1 new natural product (<b>3</b>), were isolated from <i>G. conopsea.</i> The structures of these compounds were elucidated through comprehensive spectroscopic techniques, such as 1D/2D nuclear magnetic resonance (NMR) spectroscopy, high-resolution electrospray ionization mass spectrometry (HRESIMS), and quantum chemical calculations. An oxygen–glucose deprivation/reoxygenation (OGD/R)-injured rat pheochromocytoma (PC12) cell model was used to evaluate the antistroke effects of the isolates. Compounds <b>1–2</b>, <b>10–11</b>, <b>13–15</b>, and <b>17</b> provided varying degrees of protection against OGD/R injury in the PC12 cells at concentrations of 12.5, 25, and 50 µM. Among the tested compounds, compound <b>17</b> demonstrated the most potent neuroprotective effect, which was equivalent to that of the positive control drug (edaravone). Then, transcriptomic and bioinformatics analyses were conducted to reveal the regulatory effect of compound <b>17</b> on gene expression. In addition, quantitative real-time PCR (qPCR) was performed to verify the results of the transcriptomic and bioinformatics analyses. These results suggest that the in vitro antistroke effect of compound <b>17</b> may be associated with the regulation of the <i>Col27a1</i> gene. Thus, compound <b>17</b> is a promising candidate for the development of novel antistroke drugs derived from natural products, and this topic should be further studied.https://www.mdpi.com/1420-3049/29/18/4389<i>Gymnadenia conopsea</i>bioactivity-guided separation strategyantistroke effect<i>Col27a1</i> gene
spellingShingle Juan Qin
Shiyi Xue
Chao Xu
Jian Jin
Jianbin Wang
Hailian Yuan
Liang Liu
Bioactivity-Guided Isolation of Antistroke Compounds from <i>Gymnadenia conopsea</i> (L.) R. Br.
Molecules
<i>Gymnadenia conopsea</i>
bioactivity-guided separation strategy
antistroke effect
<i>Col27a1</i> gene
title Bioactivity-Guided Isolation of Antistroke Compounds from <i>Gymnadenia conopsea</i> (L.) R. Br.
title_full Bioactivity-Guided Isolation of Antistroke Compounds from <i>Gymnadenia conopsea</i> (L.) R. Br.
title_fullStr Bioactivity-Guided Isolation of Antistroke Compounds from <i>Gymnadenia conopsea</i> (L.) R. Br.
title_full_unstemmed Bioactivity-Guided Isolation of Antistroke Compounds from <i>Gymnadenia conopsea</i> (L.) R. Br.
title_short Bioactivity-Guided Isolation of Antistroke Compounds from <i>Gymnadenia conopsea</i> (L.) R. Br.
title_sort bioactivity guided isolation of antistroke compounds from i gymnadenia conopsea i l r br
topic <i>Gymnadenia conopsea</i>
bioactivity-guided separation strategy
antistroke effect
<i>Col27a1</i> gene
url https://www.mdpi.com/1420-3049/29/18/4389
work_keys_str_mv AT juanqin bioactivityguidedisolationofantistrokecompoundsfromigymnadeniaconopseailrbr
AT shiyixue bioactivityguidedisolationofantistrokecompoundsfromigymnadeniaconopseailrbr
AT chaoxu bioactivityguidedisolationofantistrokecompoundsfromigymnadeniaconopseailrbr
AT jianjin bioactivityguidedisolationofantistrokecompoundsfromigymnadeniaconopseailrbr
AT jianbinwang bioactivityguidedisolationofantistrokecompoundsfromigymnadeniaconopseailrbr
AT hailianyuan bioactivityguidedisolationofantistrokecompoundsfromigymnadeniaconopseailrbr
AT liangliu bioactivityguidedisolationofantistrokecompoundsfromigymnadeniaconopseailrbr